Unicycive Therapeutics Inc
Research Unicycive Therapeutics Inc (UNCY) on Bullrun: market cap USD 114.49M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerUNCY
- ExchangeNASDAQ
- CountryUnited States
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 114.49M
- Financial periodQ2 2026
- RevenueUSD 0
- Net income-USD 1.72M
- Free cash flow-USD 7.60M
Valuation Snapshot
latest market cap is USD 114.49M.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 0 | -USD 26.56M | -USD 31.34M | n/a | -1.67 | USD 29.20M | USD 199.00K | USD 30.20M |
| FY2024 | USD 0 | -USD 36.73M | -USD 28.65M | n/a | -5.65 | USD 26.14M | USD 773.00K | USD 7.43M |
| FY2023 | USD 675.00K | -USD 30.54M | -USD 18.30M | n/a | -1.28 | USD 9.70M | USD 811.00K | -USD 3.81M |
| FY2022 | USD 951.00K | -USD 18.06M | -USD 15.65M | n/a | -1.2 | USD 455.00K | USD 201.00K | -USD 466.00K |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-09 | USD 114.49M | n/a | n/a | n/a |
| 2025 | 2025-12-31 | USD 127.60M | n/a | n/a | n/a |
| 2024 | 2024-12-31 | USD 90.39M | n/a | n/a | n/a |
| 2023 | 2023-12-29 | USD 30.17M | n/a | n/a | n/a |
| 2022 | 2022-12-30 | USD 8.15M | n/a | n/a | n/a |
| 2021 | 2021-12-31 | USD 30.89M | n/a | n/a | n/a |
About Unicycive Therapeutics Inc
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States. It develops oxylanthanum carbonate, a lanthanum-based phosphate binding agent, which is for the treatment of hyperphosphatemia in patients with chronic kidney disease on dialysis;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Unicycive Therapeutics Inc's market cap?
Unicycive Therapeutics Inc's market capitalization is USD 114.49M.
What does Unicycive Therapeutics Inc do?
Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies for the treatment of kidney diseases in the United States.